Asia Pacific Biological Skin Substitutes Market Size & Outlook
Related Markets
Asia Pacific biological skin substitutes market highlights
- The Asia Pacific biological skin substitutes market generated a revenue of USD 103.2 million in 2024.
- The market is expected to grow at a CAGR of 9.3% from 2025 to 2030.
- In terms of segment, human donor tissue-derived products was the largest revenue generating type in 2024.
- Human Donor Tissue-Derived Products is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 103.2 million |
| Market revenue in 2030 | USD 174.8 million |
| Growth rate | 9.3% (CAGR from 2025 to 2030) |
| Largest segment | Human donor tissue-derived products |
| Fastest growing segment | Human Donor Tissue-Derived Products |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
| Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 29.7% of the global biological skin substitutes market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 174.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biological Skin Substitutes Market Scope
Biological Skin Substitutes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Tissue Regenix | View profile | 51-100 | York, York, United Kingdom, Europe | http://www.tissueregenix.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | https://www.mallinckrodt.com |
| Organogenesis Holdings Inc Class A | View profile | 862 | 85 Dan Road, Canton, MA, United States, 02021 | https://www.organogenesis.com |
| MiMedx Group Inc | View profile | 895 | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 | https://www.mimedx.com |
| Essity AB Class B | View profile | 45900 | Klarabergsviadukten 63, PO Box 200, Stockholm, Sweden, SE-101 23 | https://www.essity.com |
| Vericel Corp | View profile | 314 | 64 Sidney Street, Cambridge, MA, United States, 02139 | https://www.vcel.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| Integra Lifesciences Holdings Corp | View profile | 3946 | 1100 Campus Road, Princeton, NJ, United States, 08540 | https://www.integralife.com |
| 3M Co | View profile | 85000 | 3M Center, St. Paul, MN, United States, 55144 | https://www.3m.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
Asia Pacific biological skin substitutes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 73.74% in 2024. Horizon Databook has segmented the Asia Pacific biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific medical device outsourcing market held the largest share 41.3% in 2023 and is expected to witness lucrative growth owing to the availability of several opportunities in this region, especially in Japan, China, and India. Some of the factors such as improved regulatory framework, high-cost savings, a large number of clinical trials conducted in the region and increase in the number of medical device companies venturing into the region are expected to drive the Asia Pacific market.
Furthermore, availability of a skilled workforce within the region at a lower cost compared to the U.S. is another factor that is anticipated to propel the market growth. Furthermore, outsourcing of certain services such as business process outsourcing, knowledge process outsourcing, clinical data management, regulatory writing, pharmacovigilance, and medical coding has witnessed an increase in the past 5 years. These services are majorly outsourced to countries such as the Philippines, India, Korea, Japan, Malaysia, Singapore, and Australia.
However, Japan is the largest market in the Asia Pacific region, majorly due to high healthcare expenditure and rapid introduction of advanced medical devices in the market. The increase in the rate of outsourcing consulting services from developed economies to emerging nations such as India and China is also expected to propel market growth over the forecast period.
Reasons to subscribe to Asia Pacific biological skin substitutes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific biological skin substitutes market databook
-
Our clientele includes a mix of biological skin substitutes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biological skin substitutes market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific biological skin substitutes market size, by country, 2018-2030 (US$M)
Asia Pacific Biological Skin Substitutes Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
